Luwad, Norpa .

HRN: 25-78-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/31/2024
09/06/2024
IV
2.25g
Q8h
CAPMR
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines